Hemmo Pharmaceuticals (Piramal Pharma Solutions)

India's first and leading manufacturer of synthetic peptides (est. 1979). Acquired by Piramal Pharma Solutions in 2021. USFDA, MHRA, and EDQM inspected GMP facility in Turbhe, Navi Mumbai. Specializes in peptide API development and commercial manufacturing using SPPS and LPPS.

Hemmo Pharmaceuticals (Piramal Pharma Solutions) is listed as a manufacturer in the peptide supply chain, serving Asia markets from India (Mumbai). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 2 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.